A3P Switzerland Congress ANNEX 1 GMP EU

The pharmaceutical and biotechnology sectors have been faced significant changes in process design, aseptic practices and contamination control requirements. This forum will provide a unique opportunity to discuss Swissmedic’s interpretation of these new requirements and to examine the strategies and challenges encountered by industry leaders in their implementation efforts.